News
FDA quietly withdraws plans for a Devices Referencing Drugs regulatory approval pathway
30 June 2020
The U.S. Food and Drug Administration recently withdrew its plans for a “Devices Referencing Drugs” (DRD) regulatory approval pathway, which it had proposed in September 2017....
